Cargando…

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV

BACKGROUND: Increased rates of cardiovascular diseases (CVD) and larger subclinical high-risk coronary plaques in coronary CT angiography have been observed in people living with HIV (PLWH) treated with antiretroviral therapy (ART) compared to HIV-uninfected people. Growth differentiation factor-15...

Descripción completa

Detalles Bibliográficos
Autores principales:	Royston, Léna, Isnard, Stéphane, Perrin, Nils, Sinyavskaya, Liliya, Berini, Carolina, Lin, John, Trottier, Benoit, Baril, Jean-Guy, Chartrand-Lefebvre, Carl, Tremblay, Cecile, Durand, Madeleine, Routy, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458883/ https://www.ncbi.nlm.nih.gov/pubmed/36093162 http://dx.doi.org/10.3389/fcvm.2022.964650

Ejemplares similares

High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV
por: Alsulami, Khlood, et al.
Publicado: (2022)

Circulating β-d-Glucan as a Marker of Subclinical Coronary Plaque in Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus
por: Isnard, Stéphane, et al.
Publicado: (2021)

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
por: Mehraj, Vikram, et al.
Publicado: (2019)

Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity
por: Ahmed, Darakhshan Sohail, et al.
Publicado: (2022)

Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers
por: Isnard, Stéphane, et al.
Publicado: (2022)

Epicardial fat density, coronary artery disease and inflammation in people living with HIV
por: Sadouni, Manel, et al.
Publicado: (2023)

Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals
por: Aranguren, Matheus, et al.
Publicado: (2022)

Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV
por: Royston, Léna, et al.
Publicado: (2021)

The Frequency and Function of NKG2C(+)CD57(+) Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy
por: Alsulami, Khlood, et al.
Publicado: (2023)

Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls
por: Ramendra, Rayoun, et al.
Publicado: (2019)

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
por: Durand, Madeleine, et al.
Publicado: (2017)

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study
por: Royston, Léna, et al.
Publicado: (2023)

Gut Leakage of Fungal‐Related Products: Turning Up the Heat for HIV Infection
por: Isnard, Stéphane, et al.
Publicado: (2021)

Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis
por: Bunet, Rémi, et al.
Publicado: (2023)

Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
por: Damba, Joseph Junior, et al.
Publicado: (2022)

Quantification of epicardial fat using non contrast cardiac CT in an HIV population: Reproducibility and association with other body fat indices
por: Sadouni, Manel, et al.
Publicado: (2021)

Beyond the Absence of CD4 T-Cell Count: A Novel Genetic CD4 T-Cell Deficiency Disorder With a Contingency Plan
por: Routy, Jean-Pierre, et al.
Publicado: (2021)

Never say “never the twain shall meet”: Combining antiretroviral therapy and RNA vaccine to obtain an adequate humoral immune response in people living with HIV
por: Routy, Jean-Pierre, et al.
Publicado: (2022)

Translocation of bacterial LPS is associated with self-reported cognitive abilities in men living with HIV receiving antiretroviral therapy
por: Isnard, Stéphane, et al.
Publicado: (2023)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Following the elite: Targeting immunometabolism to limit HIV pathogenesis
por: Routy, Jean-Pierre, et al.
Publicado: (2019)

Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma
por: Valantin, Marc-Antoine, et al.
Publicado: (2022)

Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
por: Bunet, Rémi, et al.
Publicado: (2021)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

Socio‐economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015
por: Mehraj, Vikram, et al.
Publicado: (2018)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer
por: Ahmed, Darakhshan Sohail, et al.
Publicado: (2021)

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report
por: Costiniuk, Cecilia T, et al.
Publicado: (2021)

Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV
por: Bedier, Helbies, et al.
Publicado: (2023)

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors
por: El-Far, Mohamed, et al.
Publicado: (2016)

Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque
por: Goel, Sunny, et al.
Publicado: (2015)

Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis
por: El-Far, Mohamed, et al.
Publicado: (2021)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
por: Mehraj, Vikram, et al.
Publicado: (2016)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)
por: Isnard, Stéphane, et al.
Publicado: (2022)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Anti-cytomegalovirus Immunoglobulin G Is Linked to CD4 T-cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers
por: Isnard, Stephane, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fnuc14abging7danorss29kufv